Search research articles
Contact Us
Filters
Showing results (291-300 of 321) with videos related to
Page
of 33
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 14, 2015
Technology for Innovation in Radiation Oncology
Indrin J Chetty, Mary K Martel, David A Jaffray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Fan Li, Yan Xu, Bovey Liu, et al.
Journal of the National Cancer Institute
|
March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapy
Steven H Lin, Thomas J George, Edgar Ben-Josef, et al.
Journal of Gastrointestinal Oncology
|
January 13, 2023
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer
Jillian R Gunther, Awalpreet S Chadha, Sushovan Guha, et al.
Ebiomedicine
|
October 30, 2016
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer
Masahisa Ohtsuka, Hui Ling, Cristina Ivan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2019
Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy
Cheng-En Hsieh, Bhanu Prasad Venkatesulu, Ching-Hsin Lee, et al.
Cancer Research
|
November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
Xiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
Gauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
Jason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Page
of 33
Search research articles
Search
Showing results (291-300 of 321) with videos related to
Sort By:
Page
of 33
International Journal of Radiation Oncology, Biology, Physics
|
October 14, 2015
Technology for Innovation in Radiation Oncology
Indrin J Chetty, Mary K Martel, David A Jaffray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Fan Li, Yan Xu, Bovey Liu, et al.
Journal of the National Cancer Institute
|
March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapy
Steven H Lin, Thomas J George, Edgar Ben-Josef, et al.
Journal of Gastrointestinal Oncology
|
January 13, 2023
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer
Jillian R Gunther, Awalpreet S Chadha, Sushovan Guha, et al.
Ebiomedicine
|
October 30, 2016
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer
Masahisa Ohtsuka, Hui Ling, Cristina Ivan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2019
Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy
Cheng-En Hsieh, Bhanu Prasad Venkatesulu, Ching-Hsin Lee, et al.
Cancer Research
|
November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
Xiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
Gauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
Jason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Page
of 33